Sandham, D., Chen, W., Hardman, C., Luo, J., Xue, L., Ogg, G., & Erpenbeck, V. (2019). Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s). Wiley.

Sandham, D., W. Chen, C. Hardman, J. Luo, L. Xue, G. Ogg, and V. Erpenbeck. Fevipiprant Inhibits Prostaglandin D2 Mediated Activation of Group 2 Innate Lymphoid Cells (ILC2s). Wiley, 2019.

Sandham, D., et al. Fevipiprant Inhibits Prostaglandin D2 Mediated Activation of Group 2 Innate Lymphoid Cells (ILC2s). Wiley, 2019.